Skip to main content

Table 1 (abstract A35). Analysis of OraQuick ADVANCE cross-reactivity with plasma samples from vaccine recipients

From: Abstracts from the 4th Annual Student Medical Summit

HIV-1 Diagnostic Test

Participants Testing Reactive

n (%)

p value vs OraQuick ADVANCE

OraQuick ADVANCE

1 of 57 (1.8%)

----

BioRad GS

53 of 57 (93%)

< 0.0001

Abbott Architect

54 of 57 (95%)

< 0.0001

Alere Determine

52 of 57 (91%)

< 0.0001

Abbott Prism1

1 of 1 (100%)

----

  1. 1 Abbott Prism was only used if samples tested negative on all three of the fourth-generation antigen/antibody tests (n=15)
Back to article page

BMC Proceedings

ISSN: 1753-6561

Contact us